Pyrosequencing And Cleveland Clinic to Develop Diagnostic Tests For Infectious Bacteria
PYROSEQUENCING AND CLEVELAND CLINIC TO DEVELOP DIAGNOSTIC TESTS FOR INFECTIOUS BACTERIA Uppsala, Sweden, and Cleveland, OH, November 5, 2001-Pyrosequencing AB's Molecular Diagnostics Business Unit (Stockholm: PYRO A) and The Cleveland Clinic Foundation today announced a collaborative research agreement to develop methods for the rapid identification of mycobacteria using PyrosequencingTM technology. Slow-growing mycobacteria cause infections such as tuberculosis, which is estimated to cause morbidity and mortality in one-fifth of the world's population. The detection and identification of